Akhondali Zahra, Badavi Mohammad, Dianat Mahin, Faraji Farzaneh
Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR.
Arq Bras Cardiol. 2015 Sep;105(3):235-40. doi: 10.5935/abc.20150086. Epub 2015 Jul 31.
One of the most important thyroid hormone targets is the cardiovascular system. Hemodynamic changes, such as decreased resting heart rate (HR), myocardial contractility, and cardiac output, and increased diastolic pressure and systemic vascular resistance, have been observed in hypothyroid patients. Moreover, in these patients, ECG changes include sinus bradycardia and low voltage complexes (P waves or QRS complexes).
This study aimed at evaluating the prophylactic effect of apelin on HR changes and QRS voltage that occur in propylthiouracil (PTU)-induced hypothyroid rats.
In this study, 48 adult male Wistar rats weighing 170-235g were randomly divided into 6 groups: Control group (normal saline ip injection + tap water gavage); P group (PTU 0.05%, in drinking water); A group (apelin 200 µg.kg-1.day-1, ip); PA group [co-administration of PTU and apelin]; PT group [co-administration of PTU + T4 (0.2 mg/g per day, gavage)]; and PAT group (co-administration of PTU, apelin and T4). All experiments were performed for 28 consecutive days, and then the animals were anesthetized with an ip injection of ketamine (80 mg/kg) and xylazine (12 mg/kg). Lead II electrocardiogram was recorded to calculate HR and QRS voltage.
Heart rate and QRS voltage increased more significantly in the hypothyroid group that consumed both apelin and T4 (201 ± 4 beat/min, 0.71 ± 0.02 mv vs. hypothyroid 145 ± 9 beat/min, 0.563 ± 0.015 mv; respectively).
The co-administration of apelin and T4 showed a protective effect on QRS voltage and HR in PTU‑induced hypothyroid rats.
甲状腺激素最重要的靶器官之一是心血管系统。甲状腺功能减退患者可出现血流动力学变化,如静息心率(HR)、心肌收缩力和心输出量降低,舒张压和全身血管阻力增加。此外,这些患者的心电图变化包括窦性心动过缓和低电压复合波(P波或QRS复合波)。
本研究旨在评估阿帕琳对丙硫氧嘧啶(PTU)诱导的甲状腺功能减退大鼠HR变化和QRS电压的预防作用。
本研究中,将48只体重170 - 235g的成年雄性Wistar大鼠随机分为6组:对照组(腹腔注射生理盐水 + 灌胃自来水);P组(饮用水中含0.05% PTU);A组(阿帕琳200µg·kg-1·天-1,腹腔注射);PA组[PTU与阿帕琳联合给药];PT组[PTU + T4(0.2mg/g每天,灌胃)联合给药];PAT组(PTU、阿帕琳和T4联合给药)。所有实验连续进行28天,然后腹腔注射氯胺酮(80mg/kg)和赛拉嗪(12mg/kg)对动物进行麻醉。记录II导联心电图以计算HR和QRS电压。
同时给予阿帕琳和T4的甲状腺功能减退组心率和QRS电压升高更为显著(分别为201±4次/分钟,0.71±0.02mV,而甲状腺功能减退组为145±9次/分钟,0.563±0.015mV)。
阿帕琳和T4联合给药对PTU诱导的甲状腺功能减退大鼠的QRS电压和HR具有保护作用。